Innate Pharma S.A. (IPHA)
NASDAQ·Healthcare·Biotechnology
$1.41
+0.71%
Mkt Cap $150.90M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q3 2025 Sep 17, 2025 | $1.96M | $5.72M | +191.96% | -$0.14 | -$0.29 | -106.48% | — | — |
| Q2 2025 May 12, 2025 | $18.24M | $285.80K | -98.43% | -$0.27 | -$0.32 | -18.31% | — | — |
| Q4 2020 Nov 17, 2020 | $39.74M | $41.35M | +4.03% | -$0.34 | -$0.15 | +56.14% | — | — |
| Q2 2020 May 12, 2020 | $19.07M | $19.73M | +3.45% | -$0.43 | -$0.59 | -36.63% | — | — |
| Q4 2019 Nov 13, 2019 | — | $58.58M | — | — | $0.23 | — | — | — |
| Q2 2019 May 15, 2019 | — | $84.79M | — | — | $0.36 | — | — | — |
| Q2 2018 Jun 30, 2018 | — | $26.69M | — | — | -$0.30 | — | — | — |
| Q4 2017 Dec 31, 2017 | — | $26.70M | — | — | -$0.54 | — | — | — |
| Q2 2017 Jun 30, 2017 | — | $24.24M | — | — | -$0.49 | — | — | — |
| Q4 2016 Dec 31, 2016 | — | $47.24M | — | — | $0.30 | — | — | — |
| Q2 2016 Jun 30, 2016 | — | $22.99M | — | — | -$0.07 | — | — | — |
| Q4 2015 Dec 31, 2015 | — | $22.37M | — | — | $0.03 | — | — | — |
| Q2 2015 Jun 30, 2015 | — | $5.14M | — | — | -$0.17 | — | — | — |
| Q4 2014 Dec 31, 2014 | — | $4.53M | — | — | -$0.26 | — | — | — |
| Q2 2014 Jun 30, 2014 | — | $5.64M | — | — | -$0.26 | — | — | — |
| Q4 2013 Dec 31, 2013 | — | $12.85M | — | — | -$0.02 | — | — | — |
| Q2 2013 Jun 30, 2013 | — | $9.10M | — | — | -$0.08 | — | — | — |
| Q4 2012 Dec 31, 2012 | — | $8.47M | — | — | -$0.04 | — | — | — |
| Q2 2012 Jun 30, 2012 | — | $4.77M | — | — | -$0.07 | — | — | — |
| Q4 2011 Dec 31, 2011 | — | $7.65M | — | — | -$0.12 | — | — | — |